Medical oncology

1 – 10 of 694

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/organization/V1000463?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
2
3
4
…
69
70
next »

2026
Mark Ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer (HYPO-RT-PC) : 10-year outcomes of an open-label, randomised, phase 3, non-inferiority trial
Nilsson, Per ^LU ; Gunnlaugsson, Adalsteinn ^LU ; Beckman, Lars ; Widmark, Anders ; Fransson, Per ; Hoyer, Morten ; Lagerlund, Magnus ; Kindblom, Jon ; Johansson, Bengt and Björnlinger, Kirsten , et al. (2026) In The Lancet. Oncology 27(3). p.293-301
- Contribution to journal › Article
Mark Survival in mantle cell lymphoma patients burdened by a second primary malignancy
Abalo, Kossi D. ; Trab, Trine ; Baech, Joachim ; Ekberg, Sara ^LU ; Pahnke, Simon ; Albertsson-Lindblad, Alexandra ^LU ; Smedby, Karin E. ; Jerkeman, Mats ^LU ; Brown, Peter and Larsen, Thomas Stauffer , et al. (2026) In Leukemia and Lymphoma 67(4). p.821-831
- Contribution to journal › Article
Mark Accounting for the Scarcity of Time as Patients Approach End of Life: The Construction of End-Weighted Time Toxicity
Jacobsen, Juliet ^LU ; Mahajan, Sanjoy ^LU ; Ekstrand, Joakim ^LU ; Boo Hammas, Karin ^LU ; May, Peter and Klintman, Jenny ^LU (2026) In Value in Health 29(5). p.831-839
- Contribution to journal › Article
Mark Multiomic profiling of ER-positive HER2-negative breast cancer reveals markers associated with metastatic spread
Mosquim Junior, Sergio ^LU ; Zamore, Måns ^LU ; Vallon-Christersson, Johan ^LU ; Rydén, Lisa ^LU and Levander, Fredrik ^LU (2026) In Breast Cancer Research 28(1).
- Contribution to journal › Article
Mark Dose-response relationships in neuroendocrine tumours treated with peptide receptor radionuclide therapy
Warfvinge, Carl Fredrik ^LU (2026) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
Mark Disease progression more than 6 years after treatment impacts overall survival in mantle cell lymphoma
Ekberg, Sara ; Glimelius, Ingrid ; Albertsson-Lindblad, Alexandra ^LU ; Smedby, Karin E. ; Jerkeman, Mats ^LU and Dietrich, Caroline E. (2026) In International Journal of Cancer 158(7). p.1836-1845
- Contribution to journal › Article
Mark Modeling anti-tumor immune responses using patient-derived melanoma organoids
Kaminska, Kamila ^LU ; Phung, Bengt ^LU ; Karlström, Jacob ^LU ; Lauss, Martin ^LU ; Harbst, Katja ^LU ; Svensson, Teresa ^LU ; Pietras, Kristian ^LU ; Nielsen, Kari ^LU ; Carneiro, Ana ^LU and Ekedahl, Henrik ^LU , et al. (2026) In Cancer Immunology, Immunotherapy 75(1).
- Contribution to journal › Article
Mark Feasibility of patient-reported outcomes collection in clinical routine at a radiotherapy department
Kristensen, Ingrid Fagerström ^LU ; Jerkeman, Mats ^LU ; Linnér, Anton ; Nilsson, Martin P. ^LU ; Rogowski, Viktor ^LU and Munck af Rosenschöld, Per ^LU (2026) In Acta Oncologica 65. p.326-332
- Contribution to journal › Article
Mark Psychological Resilience and Quality of Life in Mycosis Fungoides Patients : A BIO-MUSE Study
Johansson, Angelica ^LU ; Velickovic, Katarina ^LU ; Belfrage, Emma ^LU ; Drott, Kristina ^LU ; Johnsson, Per ^LU and Ek, Sara ^LU (2026) In Acta Dermato-Venereologica 106.
- Contribution to journal › Article
Mark The Effects of Sun Exposure and Pigmentation Phenotype on Prognosis in Metastatic Melanoma
Svensson, Teresa ^LU ; Sahlberg, Sebastian ; Carneiro, Ana ^LU ; Isaksson, Karolin ^LU ; Nielsen, Kari ^LU and Ekedahl, Henrik ^LU (2026) In Acta Dermato-Venereologica 106.
- Contribution to journal › Article

« previous
1
2
3
4
…
69
70
next »